Mineral arsenicals in traditional medicines: orpiment, realgar, and arsenolite (Q37221305)

19 August 2017

Mineral arsenicals in traditional medicines: orpiment, realgar, and arsenolite (English)

1 reference

19 August 2017

5

Michael P Waalkes

1 reference

19 August 2017

Jie Liu

1

1 reference

19 August 2017

Yuanfu Lu

series ordinal

2

1 reference

19 August 2017

Qin Wu

series ordinal

3

1 reference

19 August 2017

Robert A Goyer

series ordinal

4

1 reference

19 August 2017

language of work or name

English

0 references

publication date

7 May 2008

1 reference

Journal of Pharmacology and Experimental Therapeutics

19 August 2017

1 reference

19 August 2017

326

1 reference

19 August 2017

2

1 reference

19 August 2017

363-368

1 reference

Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693900

From traditional Chinese medicine to rational cancer therapy.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693900

Preparation of orpiment nanoparticles and their cytotoxic effect on cultured leukemia K562 cells

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693900

Seafood arsenic: implications for human risk assessment

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693900

Pharmacokinetics of arsenic species in Japanese patients with relapsed or refractory acute promyelocytic leukemia treated with arsenic trioxide

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693900

Bhasmas: unique ayurvedic metallic-herbal preparations, chemical characterization

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693900

Acute promyelocytic leukemia: recent advances in therapy and molecular basis of response to arsenic therapies.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693900

The potential of arsenic trioxide in the treatment of malignant disease: past, present, and future

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693900

The metabolism of inorganic arsenic oxides, gallium arsenide, and arsine: a toxicochemical review

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693900

Mechanisms of action of arsenic trioxide.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693900

Toxic heavy metals and undeclared drugs in Asian herbal medicines

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693900

Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693900

Arsenite as the probable active species in the human carcinogenicity of arsenic: mouse micronucleus assays on Na and K arsenite, orpiment, and Fowler's solution

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693900

Arsenic trioxide (As2O3) reduces the invasive and metastatic properties of cervical cancer cells in vitro and in vivo

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693900

Evaluation of the in vitro activity and in vivo bioavailability of realgar nanoparticles prepared by cryo-grinding

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693900

Effective treatment of advanced solid tumors by the combination of arsenic trioxide and L-buthionine-sulfoximine

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693900

Effect of arsenic exposure on alveolar macrophage function. II. Effect of slightly soluble forms of As(III) and As(V).

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693900

Survival after a lethal dose of arsenic trioxide

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693900

Kinetics and mechanism of As2S3(am) dissolution under N2.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693900

Evaluation of chemical constituents and free-radical scavenging activity of Swarnabhasma (gold ash), an ayurvedic drug

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693900

Public Health Risks from Heavy Metals and Metalloids Present in Traditional Chinese Medicines

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693900

Solubility, retention, and metabolism of intratracheally and orally administered inorganic arsenic compounds in the hamster

4 December 2018

1 reference

12 December 2020

Tumorigenicity of inorganic arsenic compounds following intratracheal instillations to the lungs of hamsters

1 reference

12 December 2020

Induction of metallothionein by arsenicals in mice

1 reference

12 December 2020

[Chronic arsenic poisoning caused by long-term taken Niuhuang Ninggong tablet: a report of 2 cases]

1 reference

12 December 2020

[Chronic hepatic damage in acute promyelocytic leukemia patients treated with tetra-arsenic tetra-sulfide]

1 reference

12 December 2020

Chinese folk treatment reveals power of arsenic to treat cancer, new studies under way

1 reference

12 December 2020

Bioaccessibility and excretion of arsenic in Niu Huang Jie Du Pian pills

1 reference

12 December 2020

Sudden death among patients with acute promyelocytic leukemia treated with arsenic trioxide

1 reference

12 December 2020

Tetra-arsenic tetra-sulfide for the treatment of acute promyelocytic leukemia: a pilot report

1 reference

12 December 2020

Systemic availability of arsenic from oral arsenic-trioxide used to treat patients with hematological malignancies

1 reference

12 December 2020

[A review of the research on malignant hemopathies treated with arsenium-containing Chinese drugs]

1 reference

12 December 2020

Direct cardiac effects of As2O3 in rabbits: evidence of reversible chronic toxicity and tissue accumulation of arsenicals after parenteral administration

1 reference

12 December 2020

[Effect of the tetra-arsenic tetra-sulfide (As4S4) on the corrected QT interval in the treatment of acute promyelocytic leukemia]

1 reference

12 December 2020

Identifiers

DOI

10.1124/JPET.108.139543

1 reference

19 August 2017

1 reference

19 August 2017

1 reference